Clinical Research Alert: At-Home Research Study in People with DM1

Sanguine Biosciences, a provider of at-home clinical research services, is seeking people living with myotonic dystrophy type 1 (DM1) to participate in a natural history. The goal of this research is to enhance the understanding of DM1 to support development of new diagnostic and treatment options for people living with the condition.

The study

This study is observational and does not test a new intervention or drug. Participants will be asked to provide a blood and urine sample during a one-time at-home visit by a mobile phlebotomist.

Study criteria

To be eligible, individuals must meet the following criteria:

• Diagnosed with myotonic dystrophy type 1
• Age 18-85 years of age
• Willing and able to provide appropriate written informed consent (as applicable)
• Willing and able to provide a non-expired, government-issued photo identification to mobile phlebotomist for verification of identity

Individuals may not be eligible to participate if they are affected by a condition that would interfere with the ability to undergo safe testing. This may include another illness or pregnancy, treatment with an investigational drug, or recent donation or receipt of blood.

Interested in participating?

To learn more or see if you qualify, contact the research coordinator Emory Bowen by phone: 855-836-4759 or email: ebowen@sanguinebio.com.